Am. J. Respir. Crit. Care Med., Volume 161, Number 3, March 2000, 918-921

Transient Effect of Inhaled Fluticasone on Airway Mucosal Blood Flow in Subjects with and without Asthma

SUNIL D. KUMAR, JORGE L. BRIEVA, IGNACIO DANTA, and ADAM WANNER

Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Miami School of Medicine at Mount Sinai Medical Center, Miami Beach, Florida

Topically applied glucocorticosteroids (GS) have been shown to cause local vasoconstriction in normal skin and this phenomenon is commonly used to assess the potency of topical GS (McKenzie skin blanching test). The purpose of the present study was to determine if an inhaled GS, fluticasone propionate (FP), similarly leads to vasoconstriction in the airway mucosa and if subjects with and without asthma have differential vascular responsiveness to GS. In 10 nonsmokers with stable asthma and 10 nonasthmatic nonsmokers, airway mucosal blood flow (aw) expressed per milliliter of anatomical dead space and the forced expiratory volume in 1 s (FEV ₁) were determined before and serially after inhalation of FP (88 to 1,760 µg) or placebo. Baseline mean (± SE) aw was 55.1 ± 1.0 and 44.2 ± 1.1 µl · min¹ · ml¹ in subjects with and without asthma, respectively (p < 0.001). The corresponding mean FEV₁ values were 2.34 ± 0.13 and 3.22 ± 0.12 L (p < 0.001). FP at 880 µg but not placebo produced a transient decrease in mean aw with a nadir at 30 min and return toward baseline at 90 min postinhalation; the maximum mean decrease was 37% in subjects with asthma and 21% in unaffected subjects (p < 0.01); 880 µg of FP was the lowest effective dose. FEV₁ did not change after FP administration in either group. These results demonstrate a transient vasoconstrictive action of inhaled FP in the airway mucosa, with a greater vascular responsiveness in subjects with asthma than in unaffected subjects. The measurement of aw may provide a more relevant means of assessing the potency of inhaled GS than the McKenzie skin blanching test. In addition, our observation suggests that inhaled GS have potentially beneficial effects in asthma that is not related to their antiinflammatory action. Kumar SD, Brieva JL, Danta I, Wanner A. Transient effect of inhaled fluticasone on airway mucosal blood flow in subjects with and without asthma.

This article has been cited by other articles:

				D. D. Noble, J. B. McCafferty, A. P. Greening, and J. A. Innes Respiratory heat and moisture loss is associated with eosinophilic inflammation in asthma Eur. Respir. J., April 1, 2007; 29(4): 676 - 681. [Abstract] [Full Text] [PDF]

				G. Horvath, N. Schmid, M. A. Fragoso, A. Schmid, G. E. Conner, M. Salathe, and A. Wanner Epithelial Organic Cation Transporters Ensure pH-Dependent Drug Absorption in the Airway Am. J. Respir. Cell Mol. Biol., January 1, 2007; 36(1): 53 - 60. [Abstract] [Full Text] [PDF]

				G. J. Rodrigo Rapid effects of inhaled corticosteroids in acute asthma: an evidence-based evaluation. Chest, November 1, 2006; 130(5): 1301 - 1311. [Abstract] [Full Text] [PDF]

				W. ten Hove, L. A. Houben, J. A. M. Raaijmakers, L. Koenderman, and M. Bracke Rapid Selective Priming of Fc{alpha}R on Eosinophils by Corticosteroids J. Immunol., November 1, 2006; 177(9): 6108 - 6114. [Abstract] [Full Text] [PDF]

				G. Horvath and A. Wanner Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma Eur. Respir. J., January 1, 2006; 27(1): 172 - 187. [Abstract] [Full Text] [PDF]

				G. J. Rodrigo Comparison of Inhaled Fluticasone with Intravenous Hydrocortisone in the Treatment of Adult Acute Asthma Am. J. Respir. Crit. Care Med., June 1, 2005; 171(11): 1231 - 1236. [Abstract] [Full Text] [PDF]

				S. A. Kharitonov and P. J. Barnes Effects of Corticosteroids on Noninvasive Biomarkers of Inflammation in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2004; 1(3): 191 - 199. [Abstract] [Full Text] [PDF]

				A. Wanner, G. Horvath, J. L. Brieva, S. D. Kumar, and E. S. Mendes Nongenomic Actions of Glucocorticosteroids on the Airway Vasculature in Asthma Proceedings of the ATS, November 1, 2004; 1(3): 235 - 238. [Abstract] [Full Text] [PDF]

				J. M. Pinto, P. Assanasen, F. M. Baroody, E. Naureckas, J. Solway, and R. M. Naclerio Treatment of Nasal Inflammation Decreases the Ability of Subjects with Asthma to Condition Inspired Air Am. J. Respir. Crit. Care Med., October 15, 2004; 170(8): 863 - 869. [Abstract] [Full Text] [PDF]

				E. S. Mendes, M. A. Campos, A. Hurtado, and A. Wanner Effect of Montelukast and Fluticasone Propionate on Airway Mucosal Blood Flow in Asthma Am. J. Respir. Crit. Care Med., May 15, 2004; 169(10): 1131 - 1134. [Abstract] [Full Text] [PDF]

				B. Luijk, R.D. Kempsford, A.M. Wright, P. Zanen, and J-W.J. Lammers Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchoconstriction Eur. Respir. J., April 1, 2004; 23(4): 559 - 564. [Abstract] [Full Text] [PDF]

				R. Buhl and S. G. Farmer Current and Future Pharmacologic Therapy of Exacerbations in Chronic Obstructive Pulmonary Disease and Asthma Proceedings of the ATS, April 1, 2004; 1(2): 136 - 142. [Abstract] [Full Text] [PDF]

				G. J. Rodrigo, C. Rodrigo, and J. B. Hall Acute Asthma in Adults: A Review Chest, March 1, 2004; 125(3): 1081 - 1102. [Abstract] [Full Text] [PDF]

				E. R. McFadden Jr. Acute Severe Asthma Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 740 - 759. [Abstract] [Full Text] [PDF]

				G. Horvath, Z. Sutto, A. Torbati, G. E. Conner, M. Salathe, and A. Wanner Norepinephrine transport by the extraneuronal monoamine transporter in human bronchial arterial smooth muscle cells Am J Physiol Lung Cell Mol Physiol, October 1, 2003; 285(4): L829 - L837. [Abstract] [Full Text] [PDF]

				E.S. Mendes, A. Pereira, I. Danta, R.C. Duncan, and A. Wanner Comparative bronchial vasoconstrictive efficacy of inhaled glucocorticosteroids Eur. Respir. J., June 1, 2003; 21(6): 989 - 993. [Abstract] [Full Text] [PDF]

				A. Chetta, A. Zanini, A. Foresi, M. Del Donno, A. Castagnaro, R. D'Ippolito, S. Baraldo, R. Testi, M. Saetta, and D. Olivieri Vascular Component of Airway Remodeling in Asthma Is Reduced by High Dose of Fluticasone Am. J. Respir. Crit. Care Med., March 1, 2003; 167(5): 751 - 757. [Abstract] [Full Text] [PDF]

				G. Horvath, A. Torbati, G. E. Conner, M. Salathe, and A. Wanner Systemic Ovalbumin Sensitization Downregulates Norepinephrine Uptake by Rabbit Aortic Smooth Muscle Cells Am. J. Respir. Cell Mol. Biol., December 1, 2002; 27(6): 746 - 751. [Abstract] [Full Text] [PDF]

				A.A. Acuna, J. Gabrijelcic, E.M. Uribe, R. Rabinovich, J. Roca, J.A. Barbera, K.F. Chung, and R. Rodriguez-Roisin Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma Eur. Respir. J., May 1, 2002; 19(5): 872 - 878. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Asthma, Airway Biology, and Allergic Rhinitis in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1559 - 1580. [Full Text] [PDF]

				G. Horvath, T. Lieb, G. E. Conner, M. Salathe, and A. Wanner Steroid Sensitivity of Norepinephrine Uptake by Human Bronchial Arterial and Rabbit Aortic Smooth Muscle Cells Am. J. Respir. Cell Mol. Biol., October 1, 2001; 25(4): 500 - 506. [Abstract] [Full Text] [PDF]